Keith S. Manchester
Director, Arbutus Biopharma.
Companies
- RoivantBoard member Oct 1, 2021 to now1
- Arbutus BiopharmaBoard member Mar 16, 2015 to Aug 16, 20242
- Myovant Sciences Ltd.Board member Oct 26, 2016 to Oct 26, 20163
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Roivant ROIV15,442,623 shares4$540.6M at $35.01Sep 16, 2026
Arbutus Biopharma ABUS46,069 shares5$197.4K at $4.29Aug 14, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2026Granted 5,054 shares of Roivant4
- Jun 30, 2026Sold 200,000 shares at $35.45 of Roivant6
- Jun 30, 2026Sold 12,380 shares at $35.28 of Roivant6
- Jun 29, 2026Sold 600,000 shares at $34.59 of Roivant6
- Jun 29, 2026Sold 200,000 shares at $34.44 of Roivant6
- Jun 26, 2026Sold 325,000 shares at $34.07 of Roivant6
- Jun 26, 2026Sold 300,783 shares at $33.92 of Roivant6
- Feb 13, 2026Sold 225,000 shares at $26.50 of Roivant7
- Feb 13, 2026Sold 150,784 shares at $26.49 of Roivant7
- Feb 12, 2026Sold 275,000 shares at $26.76 of Roivant7
- Feb 12, 2026Sold 150,000 shares at $26.72 of Roivant7
- Feb 11, 2026Sold 425,000 shares at $26.67 of Roivant7
- Dec 17, 2025Sold 189,538 shares at $23.17 of Roivant8
- Dec 17, 2025Sold 155,076 shares at $23.02 of Roivant8
- Dec 17, 2025Sold 432,718 shares at $23.05 of Roivant8
- Dec 16, 2025Sold 642,282 shares at $23.08 of Roivant8
- Dec 16, 2025Sold 275,000 shares at $22.93 of Roivant8
- Nov 19, 2025Sold 175,000 shares at $20.24 of Roivant9
- Nov 19, 2025Sold 125,000 shares at $20.16 of Roivant9
- Nov 19, 2025Sold 150,000 shares at $20.20 of Roivant9
- Nov 19, 2025Sold 850,000 shares at $20.25 of Roivant9
- Sep 10, 2025Granted 14,524 shares of Roivant10
- Jun 25, 2025Other 1,170,646 shares of Roivant11
- Jun 25, 2025Other 6,837,266 shares of Roivant11
- Jun 25, 2025Other 3,176,245 shares of Roivant11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRoivant, Board member
- 2SEC EDGARArbutus Biopharma, Board member
- 3SEC EDGARMyovant Sciences Ltd., Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 30, 2026
- 7SEC EDGARForm 4 filed Feb 13, 2026
- 8SEC EDGARForm 4 filed Dec 18, 2025
- 9SEC EDGARForm 4 filed Nov 21, 2025
- 10SEC EDGARForm 4 filed Sep 12, 2025
- 11SEC EDGARForm 4 filed Jun 27, 2025